comparemela.com

Latest Breaking News On - Dan peisert - Page 2 : comparemela.com

ASRT 9-DAY DEADLINE ALERT: Hagens Berman, National Trial

SAN FRANCISCO, Feb. 25, 2024 (GLOBE NEWSWIRE) Hagens Berman urges Assertio Holdings, Inc. (NASDAQ: ASRT) investors who suffered substantial losses to.

Zydus lifesciencesHagens bermanAssertio indocinDan peisertReed kathreinAssertio holdingsAssertio holdings incSidoti companyPlaintiff deadlineSecurities fraud class actionSpectrum acquisitionCompetitive generic therapiesHagens berman sobol shapiro llpSrt class actionSrt investor fraudSrt lawsuit

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Assertio Holdings, Inc of Class Action Lawsuit and Upcoming Deadlines

/PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT)..

New yorkUnited statesFrance generalTel avivCity ofUnited kingdomDan peisertLos angelesAbrahaml pomerantzRoberts willoughbyUnited states district courtPrnewswire pomerantzSecurities exchangeZydus lifesciences limitedAssertio holdings incSpectrum pharmaceuticals inc

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Assertio Holdings, Inc of Class Action Lawsuit and Upcoming Deadlines - ASRT

NEW YORK, Feb. 24, 2024 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Assertio Holdings, Inc. . The class action, filed in the United States District.

New yorkUnited statesCity ofUnited kingdomFrance generalTel avivAbrahaml pomerantzLos angelesRoberts willoughbyDan peisertZydus lifesciences limitedSpectrum pharmaceuticals incUnited states district courtPrnewswire pomerantzAssertio holdings incSecurities exchange

ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh)

If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 and would like to discuss your legal rights, call Faruqi

United statesNew yorkJosh wilsonDan peisertSpectrum pharmaceuticals incAssertio holdings incCompany indocin suppositoriesZydus lifesciences limitedDrug administrationAssertio holdingsSpectrum acquisitionSpectrum pharmaceuticalsChief executive officerDefendant dan peisertCompetitive generic therapiesDefendant peisert

ASSERTIO SHAREHOLDER NOTICE: Faruqi & Faruqi Securities

If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 and would like to discuss your.

United statesNew yorkJosh wilsonDan peisertAssertio holdings incZydus lifesciences limitedDrug administrationCompany indocin suppositoriesSpectrum pharmaceuticals incWilson faruqiAssertio holdingsSpectrum acquisitionSpectrum pharmaceuticalsChief executive officerDefendant dan peisertCompetitive generic therapies

vimarsana © 2020. All Rights Reserved.